CONDORELLI, GEROLAMA
 Distribuzione geografica
Continente #
AS - Asia 6.297
NA - Nord America 6.274
EU - Europa 4.773
SA - Sud America 768
Continente sconosciuto - Info sul continente non disponibili 285
AF - Africa 155
OC - Oceania 15
Totale 18.567
Nazione #
US - Stati Uniti d'America 5.955
SG - Singapore 2.840
RU - Federazione Russa 1.925
VN - Vietnam 1.127
CN - Cina 1.104
IT - Italia 919
BR - Brasile 633
DE - Germania 550
HK - Hong Kong 471
FI - Finlandia 312
FR - Francia 258
CA - Canada 213
BD - Bangladesh 169
NL - Olanda 162
GB - Regno Unito 135
IE - Irlanda 129
IN - India 128
SE - Svezia 115
UA - Ucraina 108
JP - Giappone 98
AR - Argentina 50
MX - Messico 48
IQ - Iraq 47
CI - Costa d'Avorio 40
ID - Indonesia 40
PH - Filippine 40
TH - Thailandia 38
ZA - Sudafrica 37
TR - Turchia 33
PL - Polonia 32
EC - Ecuador 30
ES - Italia 27
KR - Corea 23
AT - Austria 22
PK - Pakistan 22
LT - Lituania 19
TW - Taiwan 19
BE - Belgio 16
UZ - Uzbekistan 16
CO - Colombia 14
AE - Emirati Arabi Uniti 11
MA - Marocco 11
MY - Malesia 11
EG - Egitto 10
ET - Etiopia 10
JM - Giamaica 10
KE - Kenya 10
VE - Venezuela 10
CR - Costa Rica 9
CZ - Repubblica Ceca 9
JO - Giordania 9
PY - Paraguay 9
AU - Australia 8
IR - Iran 8
SA - Arabia Saudita 8
CL - Cile 7
DZ - Algeria 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
RS - Serbia 6
SN - Senegal 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
BO - Bolivia 5
CH - Svizzera 5
NP - Nepal 5
NZ - Nuova Zelanda 5
UY - Uruguay 5
GT - Guatemala 4
IL - Israele 4
RO - Romania 4
BB - Barbados 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
PA - Panama 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
BH - Bahrain 2
DM - Dominica 2
EE - Estonia 2
EU - Europa 2
GA - Gabon 2
GY - Guiana 2
HU - Ungheria 2
KH - Cambogia 2
KN - Saint Kitts e Nevis 2
KW - Kuwait 2
MD - Moldavia 2
NC - Nuova Caledonia 2
NG - Nigeria 2
PE - Perù 2
PR - Porto Rico 2
PT - Portogallo 2
TG - Togo 2
ZW - Zimbabwe 2
AL - Albania 1
AM - Armenia 1
BF - Burkina Faso 1
BS - Bahamas 1
Totale 18.254
Città #
Singapore 1.312
San Jose 1.060
Ashburn 512
Chandler 453
Hong Kong 453
Moscow 431
Ho Chi Minh City 330
Beijing 318
Munich 290
Santa Clara 284
Hanoi 239
Naples 185
Council Bluffs 165
The Dalles 165
Millbury 149
Amsterdam 146
Lauterbourg 140
Jacksonville 138
Helsinki 135
Los Angeles 133
Dallas 129
Princeton 129
Napoli 126
Boston 105
Nanjing 99
Rome 96
Ottawa 93
Buffalo 90
Hefei 86
New York 84
Tokyo 82
Wilmington 82
São Paulo 65
Frankfurt am Main 63
Phoenix 54
Haiphong 51
Des Moines 47
Turku 45
Da Nang 44
Nanchang 40
Toronto 39
Milan 38
Dong Ket 36
Houston 36
Redondo Beach 36
Montreal 34
Shenyang 34
Pune 32
Seattle 32
Orem 30
Cagliari 27
Chicago 26
Nuremberg 26
Dublin 25
Lawrence 25
Chennai 24
Denver 24
Warsaw 24
Atlanta 23
Redwood City 23
Falls Church 22
Hebei 22
Jiaxing 22
London 22
Rio de Janeiro 22
San Giorgio del Sannio 22
Washington 22
Brooklyn 21
Johannesburg 21
Tianjin 20
Baghdad 19
Can Tho 18
Changsha 17
Falkenstein 17
Woodbridge 17
Poplar 16
Verona 16
Brasília 15
Manchester 15
Mexico City 15
Norwalk 15
Biên Hòa 14
Shanghai 14
Stockholm 14
Boardman 13
Caserta 13
Hải Dương 13
Philadelphia 13
Seoul 13
Tashkent 13
Bangkok 12
Brussels 12
Dhaka 12
Mumbai 12
Ninh Bình 12
Castelvetere sul Calore 11
Quito 11
Salvador 11
San Francisco 11
Addis Ababa 10
Totale 9.872
Nome #
Recent Advance in Biosensors for microRNAs Detection in Cancer 267
Nucleic acids in human glioma treatment: innovative approaches and recent results. 251
RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway 191
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes 185
miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS 184
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors 177
MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer 176
Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer 174
Ranolazine attenuates trastuzumab-induced heart dysfunction by modulating ROS production 174
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 169
PED regulates cell migration/invasion processes in human non small cell lung cancer cells through Rac1. 168
Ultrasmall Carbon Nanodots as Theranostic Nanoheaters for Precision Breast Cancer Phototherapy: Establishing the Translational Potential in Tumor-in-a-Dish Models 166
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers 166
Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects 158
Phosphorylation-regulated degradation of the tumor-suppressor form of PED by chaperone-mediated autophagy in lung cancer cells 157
Therapeutic strategies to prevent contrast-induced acute kidney injury 157
Anti-breast cancer exosome aptamer for diagnostic and therapeutic uses 157
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL 155
Comparative Proteomic Profiling of Secreted Extracellular Vesicles from Breast Fibroadenoma and Malignant Lesions: A Pilot Study 152
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b 150
Ex.50.T aptamer impairs tumor–stroma cross-talk in breast cancer by targeting gremlin-1 149
miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer 147
Epigenetic Regulation of miR-212 Expression in Lung Cancer 142
miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells 142
In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis. 141
miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. 141
Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. 141
MiR-216a acts as a negative regulator of breast cancer by modulating stemness properties and tumor microenvironment 141
A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death. 140
PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus 139
Electrochemical detection of miRNA-222 by use of a magnetic bead-based bioassay. 139
MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p 138
Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. 138
Aptamer chimeras for therapeutic delivery: The challenging perspectives 138
Optimisation of TAP-TAG purification in PED/PEA-15 interactoma studies 137
PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells. 137
Contrast-induced acute kidney injury: Potential new strategies 135
Potential and challenges of aptamers as specific carriers of therapeutic oligonucleotides for precision medicine in cancer 134
Targeting Insulin Receptor with a Novel Internalizing Aptamer 134
Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer 134
Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury 133
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRbeta Aptamer. 130
Modulating the crosstalk between the tumor and the microenvironment using sirna: A flexible strategy for breast cancer treatment 130
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. 129
c-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3β activity. 129
miR-221/222 overexpression in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ. 129
Urinary Dickkopf-3 and Contrast-Associated Kidney Damage 128
miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. 127
"ApoptomiRs" in vascular cells: their role in physiological and pathological angiogenesis. 125
Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells 125
Novel Biomarkers for Contrast-Induced Acute Kidney Injury 124
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells 124
Antifouling strategies of nanoparticles for diagnostic and therapeutic application: A systematic review of the literature 124
Predicting survival inss glioblastoma patients using diffusion mr imaging metrics—a systematic review 123
Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study. 122
Highly Homogeneous Biotinylated Carbon Nanodots: Red-Emitting Nanoheaters as Theranostic Agents toward Precision Cancer Medicine 122
Caratterizzazione dei meccanismi molecolari del danno indotto da mezzo di contrasto in cellule renali umane. 121
Targeting Glioblastoma Stem Cells via EphA2: Structural Insights into the RNA Aptamer A40s for Precision Therapy 121
Cell Death-based therapy 120
Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial. 120
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy 120
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis. 119
RANOLAZINE AT THE END OF TRASTUZUMAB THERAPY PREVENTS LEFT VENTRICULAR DYSFUNCTION: IN VITRO AND IN VIVO STUDY 119
Endothelial progenitor cells in coronary artery disease 118
Endothelial Progenitor Cells and Percutaneous Coronary Artery Intervention: Editorial to: “Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells after Percutaneous Coronary Intervention (HIPOCRATES Study)” by A. Eisen et al 117
An anti-PDGFRβ aptamer for selective delivery of small therapeutic peptide to cardiac cells. 117
Combined targeting of glioblastoma stem-like cells by neutralizing RNA-bio-drugs for STAT3 117
Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells 117
Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death. 116
Molecular basis of impaired insulin-stimulated cardiac glucose utilization in spontaneously hypertensive rats. 115
L’ipertrofia miocardia da sovraccarico pressorio induce un notevole incremento dell’espressione di C-Flip, una proteina indispensabile per lo sviluppo embrionale del cuore 115
The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications 115
skeletal muscle, glucose storage and oxidation are differentially impaired by the IR1152 mutant receptor. J. Biol. Chem. 272:7290-7297 IF: 5.581 (14) 113
SERS-active metal-dielectric nanostructures integrated in microfluidic devices for label-free quantitative detection of miRNA 113
The role of RNA and DNA aptamers in glioblastoma diagnosis and therapy: A systematic review of the literature 112
SIROLIMUS-ELUTING STENT IMPLANTATION IN DIABETIC PATIENTS WITH MULTIVESSEL CORONARY ARTERY DISEASE 111
miR221/222 in cancer: their role in tumor progression and response to therapy. 111
Colorimetric aptasensor for exosome detection in breast cancer liquid biopsy 110
Impact of microvascular complications on outcome after coronary stent implantations in diabetic patients 110
Insulin-activated PKCb bypasses Ras and stimulates MAPKinase activity and cell proliferation in muscle cells 110
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes 110
RenalGuard system in high-risk patients for contrast-induced acute kidney injury. 110
IMPACT OF GLYCAEMIC AND LIPID CONTROL ON OUTCOME AFTER PERCUTANEOUS CORONARY INTERVENTIONS IN DIABETIC PATIENTS. 108
La tirosino fosfatasi SHP-1 come nuovo marker prognostico del carcinoma mammario umano 107
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 107
Targeting breast cancer exosomes with nucleic aptamers: Innovative tools for early diagnosis and therapy 107
Fibroblasts activated by miRs-185-5p, miR-652-5p, and miR-1246 shape the tumor microenvironment in triple-negative breast cancer via PATZ1 downregulation 107
Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction 106
Late INa Inhibition with Ranolazine Blunts Doxorubicin- Induced Cardiac Dysfunction and Remodeling in Mice 105
Functional importance of Insulin-like Growth Factor I receptor COOH-terminal region tyrosine phosphorylation sites. 105
Novel approaches for preventing or limiting events in diabetic patients (Naples-diabetes) trial: a randomized comparison of 3 drug-eluting stents in diabetic patients. 104
Autocrine production of IL-4 and IL-10 is required for survival and growth of thyroid cancer cells 103
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design. 103
UTILITY OF 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN DIAGNOSIS OF LEFT VENTRICULAR DYSFUNCTION IN ANTI-ERBB2 THERAPY 103
Insulin-like growth factor I receptor internalization regulates signaling via the Sch/Map kinase pathway, but not the insulin receptor substrate 1 pathway 102
Akt and Erk 8 activity regulation in cellular proliferation control 102
Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors. 102
Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus 101
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. 101
Vitamin D(3) signalling in the brain enhances the function of Phosphoprotein Enriched in Astrocytes - 15 KDa (PEA-15). 100
Totale 13.215
Categoria #
all - tutte 61.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022825 0 0 1 7 46 35 10 32 129 57 133 375
2022/20231.121 165 78 34 72 137 132 5 104 195 134 47 18
2023/2024886 46 135 75 67 43 165 20 108 13 14 144 56
2024/20254.725 214 288 18 54 134 378 507 352 397 424 1.593 366
2025/20268.514 913 539 850 831 1.441 310 1.032 450 1.132 522 232 262
2026/2027680 180 277 223 0 0 0 0 0 0 0 0 0
Totale 18.567